On Drugs Inc
EIN: 251232170 · State College, PA
Is On Drugs Inc Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About On Drugs Inc
On Drugs Inc (EIN: 251232170) is a nonprofit organization based in State College, PA. The organization reported total revenue of $660K and total assets of $559K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of On Drugs Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
AI Analysis Pending
AI enrichment for On Drugs Inc has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates On Drugs Inc with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Frequently Asked Questions about On Drugs Inc
Is On Drugs Inc a legitimate charity?
Based on AI analysis of IRS 990 filings, On Drugs Inc (EIN: 251232170) insufficient data. 0 red flags identified, 0 strengths noted.
How does On Drugs Inc spend its money?
Detailed spending breakdown data is not yet available for On Drugs Inc. Check back for updated IRS 990 analysis.
Are donations to On Drugs Inc tax-deductible?
On Drugs Inc is registered as a tax-exempt nonprofit (EIN: 251232170). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Filing History
IRS 990 filing history for On Drugs Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), On Drugs Inc's revenue has grown by 24.6%, moving from $400K to $499K. Total assets increased by 64.5% over the same period, from $286K to $470K. Total functional expenses rose by 34.2%, from $403K to $541K. In its most recent filing year (2023), On Drugs Inc reported a deficit of $42K, with expenses exceeding revenue. The organization holds $54K in liabilities against $470K in assets (debt-to-asset ratio: 11.5%), resulting in net assets of $416K.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. | |
|---|---|---|---|---|---|---|
| 2023 | $499K | $541K | $470K | $54K | — | View 990 |
| 2022 | $455K | $406K | $539K | $80K | — | View 990 |
| 2021 | $540K | $433K | $432K | $22K | — | — |
| 2020 | $422K | $354K | $347K | $48K | — | View 990 |
| 2019 | $422K | $403K | $242K | $12K | — | View 990 |
| 2018 | $343K | $400K | $222K | $11K | — | View 990 |
| 2017 | $326K | $355K | $277K | $9K | — | View 990 |
| 2016 | $305K | $346K | $301K | $4K | — | View 990 |
| 2015 | $338K | $356K | $349K | $11K | — | View 990 |
| 2014 | $303K | $356K | $369K | $13K | — | View 990 |
| 2013 | $338K | $260K | $415K | $6K | — | View 990 |
| 2012 | $391K | $341K | $336K | $5K | — | View 990 |
| 2011 | $400K | $403K | $286K | $6K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $499K, expenses of $541K, and assets of $470K (revenue +9.6% year-over-year).
- 2022: Revenue of $455K, expenses of $406K, and assets of $539K (revenue -15.7% year-over-year).
- 2021: Revenue of $540K, expenses of $433K, and assets of $432K (revenue +27.9% year-over-year).
- 2020: Revenue of $422K, expenses of $354K, and assets of $347K (revenue -0.1% year-over-year).
- 2019: Revenue of $422K, expenses of $403K, and assets of $242K (revenue +23.2% year-over-year).
- 2018: Revenue of $343K, expenses of $400K, and assets of $222K (revenue +5.0% year-over-year).
- 2017: Revenue of $326K, expenses of $355K, and assets of $277K (revenue +7.1% year-over-year).
- 2016: Revenue of $305K, expenses of $346K, and assets of $301K (revenue -9.9% year-over-year).
- 2015: Revenue of $338K, expenses of $356K, and assets of $349K (revenue +11.5% year-over-year).
- 2014: Revenue of $303K, expenses of $356K, and assets of $369K (revenue -10.3% year-over-year).
- 2013: Revenue of $338K, expenses of $260K, and assets of $415K (revenue -13.6% year-over-year).
- 2012: Revenue of $391K, expenses of $341K, and assets of $336K (revenue -2.2% year-over-year).
- 2011: Revenue of $400K, expenses of $403K, and assets of $286K.
Data Sources and Methodology
This transparency report for On Drugs Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.